Indian Generics 2008-2012 The Growing Threat to Westernised Markets

Indian pharmaceutical companies are grabbing headlines on an almost daily basis and are increasingly carving out market shares for themselves in the US and many other markets around the world. Several leading Indian pharmaceutical companies have applied themselves to the challenge of entering Western markets with great success. These companies now present a very serious threat to the existing Western generic companies in their domestic markets as they take ever-larger market shares and increase the levels of competition.

Why has this challenge arisen - what advantages do Indian companies enjoy that enable them to compete so successfully with Western generic companies?

It is the purpose of this report to answer that question and to provide Western pharmaceutical companies and others that are interested by this phenomenon with some explanation of the background. It will also offer some guidance as to how companies might deal with what some see as a threat and others view as a welcome source of low-cost generics.

Report Highlights and Key Findings

* Provides a unique analysis of the leading Indian companies and their areas of expertise

* Examines the factors that have led to their success

* Overview of Indian R&D efforts directed towards developing new New Chemical Entities

* Investigates the local Indian market environment

* Provides a detailed legislative background and role of government agencies in the Indian generics industry

* Analysis of current and predicted future market sizes

* Identifies the drivers of future market growth

* Looks at current and past multinational companies present in India

* Comprehensively explains local healthcare insurance systems

* Explains why Indian generics companies have been so successful

* Identifies the market leaders in the domestic market

* Explores growth strategies companies use on their way up

* Identifies when the Indian growth spurt started

* Investigates the current status of intellectual property in India

* Elucidates the opportunities in the domestic market for foreign companies

* Provides a unique assessment of the Indian generics market both currently and prospectively

* Identifies which companies are likely to be the future generic giants

* Provides insight into what Indian companies themselves see as their main competitors

* Suggests the direction that the Indian pharmaceutical industry likely to follow in the future

Features of This Report:

* Research and analysis by an expert with inside knowledge of an Indian generic company

* Provides an crucial explanation of the key elements in the growing Indian success

* Tabulates and evaluates the leading players in the Indian domestic market

* Discusses the history and future prospects of the market leaders

* Analyses the current and projected market sizes

* Includes an examination of major trends in India and their probable impact

* Provides an overview of population and social trends that will affect growth

* Offers and in-depth analysis of the IP situation and how it has changed and is likely to change in the future

Reasons to Buy This Report:

* To establish if Indian generics businesses are taking a greater share in the European and US generic markets;

* Determines the impact of Indian generics on European and US generic competitors;

* Provides an analysis of the importance of Indian API manufacturers to US markets;

* Establishes the current situation of Indian manufacturing;

* Importantly surveys the trends in India that are likely to impact Western markets.

Publication Date: January 21, 2008 Pages: 138

Table of Contents

Price
Single User PDF $3120.00
Site / Department Licence PDF $5060.00
Company-wide license PDF $7400.00